バイオマーカー検査の世界市場レポート 2025年

バイオマーカー検査市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.5％で316億3,000万米ドルに成長します。予測期間における成長の背景には、がん以外の疾患におけるバイオマーカーの適用拡大、コンパニオン診断への投資の増加、診断プロセスへの人工知能の統合の進展、ポイントオブケア検査の採用拡大、予防ヘルスケアに対する意識の高まりなどがあります。予測期間中に予想される主要動向としては、シークエンシング技術の発展、リキッドバイオプシーにおける技術革新の進展、マルチプレックスバイオマーカープラットフォームの進歩、プロテオミクスとメタボロミクスにおけるブレークスルー、研究開発投資の増加などが挙げられます。

がん負担の増加は、今後数年間におけるバイオマーカー検査市場の成長を促進すると予想されます。がんは、異常な細胞の制御不能な増殖と拡散によって特徴づけられる疾患群です。このような負担の増加は、不健康な食生活、喫煙、運動不足、過度のアルコール摂取など、ライフスタイルに関連する危険因子に大きく起因しています。バイオマーカー検査は、疾患特異的マーカーの早期かつ正確な同定を可能にすることで、診断精度を向上させ、がん発見に重要な役割を果たします。また、個別化された治療戦略を促進し、患者の転帰を改善し、より効率的なヘルスケア管理を実現します。例えば、2024年7月、オーストラリア保健福祉ラボは、2022年にオーストラリアで16万570例のがんが診断され、2021年の15万6,781例から3,789例増加したと報告しました。したがって、がんの罹患率の増加がバイオマーカー検査市場の拡大に大きく寄与しています。

バイオマーカー検査市場で事業を展開する主要企業は、診断精度を高め、疾患の早期発見を可能にし、個別化治療戦略をサポートするために、免疫組織化学（IHC）技術などの技術的に先進的なソリューションの開発に注力しています。免疫組織化学（IHC）は、抗体を利用して組織サンプル中の特定のタンパク質を検出する検査技術であり、病気の診断や研究に不可欠なバイオマーカーの同定と可視化を可能にします。例えば、米国を拠点とする医療検査会社クエスト・ダイアグノスティックスインコーポレイテッドは、2023年7月、AmeriPath事業を通じて新しい組織ベースの前立腺がんバイオマーカー検査を開始しました。この検査は、独自のバイオマーカーであるEV1、EV2、EV3を活用し、医師がより正確に進行性の前立腺がんを同定・識別できるようにすることで、診断精度を向上させています。この検査は、診断の一貫性を高め、適切な個別化治療戦略を導くことにより、臨床上の重要なニーズに応えるものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のバイオマーカー検査：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバイオマーカー検査市場：成長率分析
• 世界のバイオマーカー検査市場の実績：規模と成長、2019～2024年
• 世界のバイオマーカー検査市場の予測：規模と成長、2024～2029年、2034年
• 世界のバイオマーカー検査：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のバイオマーカー検査市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 消耗品
• 装置
• サービス
• 世界のバイオマーカー検査市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• ポリメラーゼ連鎖反応
• 次世代シーケンス
• 免疫測定
• その他
• 世界のバイオマーカー検査市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍学
• 心臓病学
• 神経学
• 感染症
• その他
• 世界のバイオマーカー検査市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 診断ラボ
• 研究機関
• その他
• 世界のバイオマーカー検査市場、消耗品のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬
• アッセイキット
• サンプル収集装置
• 化学品と緩衝剤
• 世界のバイオマーカー検査市場、装置のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ポリメラーゼ連鎖反応（PCR）システム
• 次世代シーケンス（NGS）プラットフォーム
• マイクロアレイシステム
• 質量分析装置
• 免疫測定分析装置
• 世界のバイオマーカー検査市場、サービスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• バイオマーカー探索サービス
• 診断検査サービス
• コンパニオン診断開発
• 臨床試験検査サービス
• 契約研究機関（CRO）サービス

第7章 地域別・国別分析

• 世界のバイオマーカー検査市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のバイオマーカー検査市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオマーカー検査市場：競合情勢
• バイオマーカー検査市場：企業プロファイル
  • Roche Diagnostics International Ltd.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • Merck KGaA

第31章 その他の大手企業と革新的企業

• Siemens Healthineers AG
• Becton Dickinson and Company
• GE HealthCare Technologies Inc.
• Agilent Technologies Inc.
• Illumina Inc.
• Hologic Inc.
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• Myriad Genetics Inc.
• Guardant Health Inc.
• Sino Biological Inc.
• Proteome Sciences plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• バイオマーカー検査市場、2029年：新たな機会を提供する国
• バイオマーカー検査市場、2029年：新たな機会を提供するセグメント
• バイオマーカー検査市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Biomarker testing involves examining blood, tissue, or other bodily fluids to detect specific biological indicators that signify either normal or pathological conditions. This process is vital for disease diagnosis, monitoring disease progression, and creating personalized treatment strategies.

Biomarker testing includes several product types such as consumables, instruments, services, and more. Consumables refer to items that are used and depleted during procedures and must be replenished regularly, including medical supplies, food items, or office essentials. The primary technologies employed are polymerase chain reaction (PCR), next-generation sequencing (NGS), immunoassays, among others. It is widely used in fields such as oncology, cardiology, neurology, and infectious diseases, with key end-users including hospitals, diagnostic labs, research institutions, and other healthcare settings.

The biomarker testing market research report is one of a series of new reports from The Business Research Company that provides biomarker testing market statistics, including the biomarker testing industry global market size, regional shares, competitors with the biomarker testing market share, detailed biomarker testing market segments, market trends, and opportunities, and any further data you may need to thrive in the biomarker testing industry. These biomarker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biomarker testing market size has grown rapidly in recent years. It will grow from $17.51 billion in 2024 to $19.75 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth during the historic period can be attributed to the rising adoption of personalized medicine, the increased utilization of biomarkers in oncology, the growing prevalence of chronic illnesses, expanded research funding in the life sciences sector, and the heightened demand for early disease detection.

The biomarker testing market size is expected to see rapid growth in the next few years. It will grow to $31.63 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to the expanding application of biomarkers in non-oncology conditions, increasing investments in companion diagnostics, greater integration of artificial intelligence into diagnostic processes, the rising adoption of point-of-care testing, and growing awareness of preventive healthcare. Key trends expected during the forecast period include advancements in sequencing technologies, ongoing innovations in liquid biopsy, progress in multiplex biomarker platforms, breakthroughs in proteomics and metabolomics, and rising investments in research and development.

The rising cancer burden is expected to drive the growth of the biomarker testing market in the coming years. Cancer comprises a group of diseases marked by the uncontrolled growth and spread of abnormal cells. This increasing burden is largely attributed to lifestyle-related risk factors such as unhealthy diets, smoking, physical inactivity, and excessive alcohol consumption. Biomarker testing plays a vital role in cancer detection by enabling early and accurate identification of disease-specific markers, thereby improving diagnostic precision. It also facilitates personalized treatment strategies, resulting in improved patient outcomes and more efficient healthcare management. For instance, in July 2024, the Australian Institute of Health and Welfare reported that 160,570 cancer cases were diagnosed in Australia in 2022, an increase of 3,789 cases from 156,781 in 2021. Therefore, the growing incidence of cancer is contributing significantly to the expansion of the biomarker testing market.

Major companies operating in the biomarker testing market are focusing on developing technologically advanced solutions, such as immunohistochemistry (IHC) technology, to enhance diagnostic accuracy, enable early disease detection, and support personalized treatment strategies. Immunohistochemistry (IHC) is a laboratory technique that utilizes antibodies to detect specific proteins in tissue samples, enabling the identification and visualization of biomarkers critical for disease diagnosis and research. For example, in July 2023, Quest Diagnostics Incorporated, a U.S.-based medical laboratory company, launched a new tissue-based prostate cancer biomarker test through its AmeriPath business. This test leverages proprietary biomarkers EV1, EV2, and EV3 to improve diagnostic precision by helping physicians more accurately identify and distinguish aggressive prostate cancer types. It addresses a critical clinical need by enhancing grading consistency and guiding appropriate, individualized treatment strategies.

In August 2025, Quanterix Corp., a U.S.-based life sciences company, acquired Emission Inc. for approximately $70 million. This acquisition is aimed at expanding Quanterix's technology portfolio and market presence by incorporating Emission's advanced multiplex and multi-omic assay technologies. The integration is expected to strengthen Quanterix's position in the biomarker testing sector, enhance its diagnostic capabilities, and open new market opportunities. Emission Inc. is a U.S.-based biotechnology company specializing in multiplex and multi-omic assay solutions for biomarker testing.

Major players in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

North America was the largest region in the biomarker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biomarker testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biomarker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biomarker testing market consists of revenues earned by entities by providing services such as clinical biomarker testing services, bioinformatics and data analysis services, sample collection and biobanking services, and companion diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The biomarker testing market includes sales of analytical instruments, imaging devices, lab-on-a-chip and microfluidic devices, and data acquisition and integration hardware. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the specified geography within the market, irrespective of where they are produced. They do not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomarker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomarker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomarker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biomarker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Consumables; Instruments; Services
• 2) By Technology: Polymerase Chain Reaction; Next-Generation Sequencing; Immunoassays; Other Technologies
• 3) By Application: Oncology; Cardiology; Neurology; Infectious Diseases; Other Applications
• 4) By End-User: Hospitals; Diagnostic Laboratories; Research Institutes; Other End-Users
• Subsegments:
• 1) By Consumables: Reagents; Assay Kits; Sample Collection Devices; Chemicals And Buffers
• 2) By Instruments: Polymerase Chain Reaction (PCR) Systems; Next-Generation Sequencing (NGS) Platforms; Microarray Systems; Mass Spectrometry Instruments; Immunoassay Analyzers
• 3) By Services: Biomarker Discovery Services; Diagnostic Testing Services; Companion Diagnostic Development; Clinical Trial Testing Services; Contract Research Organization (CRO) Services
• Companies Mentioned: Roche Diagnostics International Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biomarker Testing Market Characteristics

3. Biomarker Testing Market Trends And Strategies

4. Biomarker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biomarker Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biomarker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biomarker Testing Market Growth Rate Analysis
• 5.4. Global Biomarker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biomarker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biomarker Testing Total Addressable Market (TAM)

6. Biomarker Testing Market Segmentation

• 6.1. Global Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Instruments
• Services
• 6.2. Global Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction
• Next-Generation Sequencing
• Immunoassays
• Other Technologies
• 6.3. Global Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiology
• Neurology
• Infectious Diseases
• Other Applications
• 6.4. Global Biomarker Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Other End-Users
• 6.5. Global Biomarker Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents
• Assay Kits
• Sample Collection Devices
• Chemicals And Buffers
• 6.6. Global Biomarker Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR) Systems
• Next-Generation Sequencing (NGS) Platforms
• Microarray Systems
• Mass Spectrometry Instruments
• Immunoassay Analyzers
• 6.7. Global Biomarker Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biomarker Discovery Services
• Diagnostic Testing Services
• Companion Diagnostic Development
• Clinical Trial Testing Services
• Contract Research Organization (CRO) Services

7. Biomarker Testing Market Regional And Country Analysis

• 7.1. Global Biomarker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biomarker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biomarker Testing Market

• 8.1. Asia-Pacific Biomarker Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biomarker Testing Market

• 9.1. China Biomarker Testing Market Overview
• 9.2. China Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biomarker Testing Market

• 10.1. India Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biomarker Testing Market

• 11.1. Japan Biomarker Testing Market Overview
• 11.2. Japan Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biomarker Testing Market

• 12.1. Australia Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biomarker Testing Market

• 13.1. Indonesia Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biomarker Testing Market

• 14.1. South Korea Biomarker Testing Market Overview
• 14.2. South Korea Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biomarker Testing Market

• 15.1. Western Europe Biomarker Testing Market Overview
• 15.2. Western Europe Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biomarker Testing Market

• 16.1. UK Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biomarker Testing Market

• 17.1. Germany Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biomarker Testing Market

• 18.1. France Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biomarker Testing Market

• 19.1. Italy Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biomarker Testing Market

• 20.1. Spain Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biomarker Testing Market

• 21.1. Eastern Europe Biomarker Testing Market Overview
• 21.2. Eastern Europe Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biomarker Testing Market

• 22.1. Russia Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biomarker Testing Market

• 23.1. North America Biomarker Testing Market Overview
• 23.2. North America Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biomarker Testing Market

• 24.1. USA Biomarker Testing Market Overview
• 24.2. USA Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biomarker Testing Market

• 25.1. Canada Biomarker Testing Market Overview
• 25.2. Canada Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biomarker Testing Market

• 26.1. South America Biomarker Testing Market Overview
• 26.2. South America Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biomarker Testing Market

• 27.1. Brazil Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biomarker Testing Market

• 28.1. Middle East Biomarker Testing Market Overview
• 28.2. Middle East Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biomarker Testing Market

• 29.1. Africa Biomarker Testing Market Overview
• 29.2. Africa Biomarker Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biomarker Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biomarker Testing Market Competitive Landscape And Company Profiles

• 30.1. Biomarker Testing Market Competitive Landscape
• 30.2. Biomarker Testing Market Company Profiles
  • 30.2.1. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Biomarker Testing Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers AG
• 31.2. Becton Dickinson and Company
• 31.3. GE HealthCare Technologies Inc.
• 31.4. Agilent Technologies Inc.
• 31.5. Illumina Inc.
• 31.6. Hologic Inc.
• 31.7. Charles River Laboratories International Inc.
• 31.8. PerkinElmer Inc.
• 31.9. Sysmex Corporation
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. DiaSorin S.p.A.
• 31.12. Myriad Genetics Inc.
• 31.13. Guardant Health Inc.
• 31.14. Sino Biological Inc.
• 31.15. Proteome Sciences plc

32. Global Biomarker Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biomarker Testing Market

34. Recent Developments In The Biomarker Testing Market

35. Biomarker Testing Market High Potential Countries, Segments and Strategies

• 35.1 Biomarker Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biomarker Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biomarker Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer